Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fine

Showing results (211-220 of 241) with videos related to

Pageof 25
Sort By:
JAMA Oncology|November 10, 2017
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate CancerJosef J Fox, Somali C Gavane, Estelle Blanc-Autran, et al.
Human Pathology|March 31, 2018
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinomaSumit Isharwal, Hongying Huang, Gouri Nanjangud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
The American Journal of Surgical Pathology|June 23, 2025
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The ProstateKenneth A Iczkowski, Angelo M De Marzo, Neeraj Agarwal, et al.
Histopathology|January 29, 2014
Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologistsAmanda H Seipel, Brett Delahunt, Hemamali Samaratunga, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary TractSounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
The American Journal of Surgical Pathology|October 11, 2019
TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic CorrelationsSounak Gupta, Pedram Argani, Achim A Jungbluth, et al.
Mayo Clinic Proceedings|June 26, 2022
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling InhibitorsSounak Gupta, Paige Nichols, Christine M Lohse, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 14, 2017
#InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of PathologyDavid Cohen, Timothy Craig Allen, Serdar Balci, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical managementSounak Gupta, John C Cheville, Achim A Jungbluth, et al.
Pageof 25

Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
JAMA Oncology|November 10, 2017
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate CancerJosef J Fox, Somali C Gavane, Estelle Blanc-Autran, et al.
Human Pathology|March 31, 2018
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinomaSumit Isharwal, Hongying Huang, Gouri Nanjangud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
The American Journal of Surgical Pathology|June 23, 2025
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The ProstateKenneth A Iczkowski, Angelo M De Marzo, Neeraj Agarwal, et al.
Histopathology|January 29, 2014
Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologistsAmanda H Seipel, Brett Delahunt, Hemamali Samaratunga, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 24, 2022
<i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary TractSounak Gupta, Chad M Vanderbilt, Yanming Zhang, et al.
The American Journal of Surgical Pathology|October 11, 2019
TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic CorrelationsSounak Gupta, Pedram Argani, Achim A Jungbluth, et al.
Mayo Clinic Proceedings|June 26, 2022
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling InhibitorsSounak Gupta, Paige Nichols, Christine M Lohse, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 14, 2017
#InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of PathologyDavid Cohen, Timothy Craig Allen, Serdar Balci, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical managementSounak Gupta, John C Cheville, Achim A Jungbluth, et al.
Pageof 25